Real-time enrollment status for this follicular lymphoma clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 10:54 AM UTC
| NCT Number | NCT06091254 |
| Recruiting Status | Recruiting |
| Condition | Follicular Lymphoma |
| Phase | PHASE3 |
| Target Enrollment | 822 participants |
| Active Locations | 20 sites in the US |
| Sponsor | Regeneron Pharmaceuticals |
| Last Updated on CT.gov | June 24, 2026 (3 weeks ago) |
As of July 17, 2026: Clinical trial NCT06091254 is currently recruiting participants. This phase3 study for follicular lymphoma is actively seeking new participants at 20 locations across the United States. The study is sponsored by Regeneron Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06091254 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 20 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06091254 was last updated 3 weeks ago (June 24, 2026). HelloStudys verifies this status automatically.